Completed PHASE2 INTERVENTIONAL 3-arm NCT03101124

Serum Concentration of Tranexamic Acid After Topical Administration in Massive Weight Loss Skin Reducing Surgery

Sponsor: Aleris Helse

Interventions Tranexamic Acid 25 mg/ml for wound surface moistening Tranexamic Acid 5 mg/ml as bolus in wound cavity Tranexamic Acid Injectable Solution

Updated 9 times since 2017 Last updated: Aug 15, 2019 Started: May 1, 2017 Primary completion: Feb 28, 2018 Completion: Feb 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Bleeding and Surgical Wound and is currently completed. Aleris Helse leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Sep 2019 — Jan 2021 [monthly]

Completed PHASE2
Dec 2018 — Sep 2019 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed

▶ Show 4 earlier versions

Jun 2018 — Dec 2018 [monthly]

Active Not Recruiting PHASE2
Mar 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Oct 2017 — Mar 2018 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
May 2017 — Oct 2017 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aleris Helse
St. Olavs Hospital

Data source: St. Olavs Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Trondheim, Norway